Vascular endothelial growth factor overexpression positively modulates the characteristics of periprosthetic tissue of polyurethane-coated silicone breast implant in rats

Plastic and Reconstructive Surgery

Volumn 126, Issue 6, 2010, Pages 1899-1910

  Vieira, Vilberto J ^a,b,c   D'Acampora, Armando J ^a,b,c   Marcos, Ana Beatriz W ^a,b,c   Di Giunta, Gabriella ^a,b,c   De Vasconcellos, Zulmar A A ^a,b,c   Bins Ely, Jorge ^a,b,c   D'Eça Neves, Rodrigo ^a,b,c   Figueiredo, Cláudia P ^a,b,c  

^a Centro de Ciências da Educação   (Brazil)

^b Hospital Universitario   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BIOMATERIAL; POLYURETHAN; SILICONE GEL; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANIMAL; ARTICLE; BREAST ENDOPROSTHESIS; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOREIGN BODY REACTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SURFACE PROPERTY; WISTAR RAT; WOUND HEALING;

ACTINS; ANIMALS; BREAST IMPLANTS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FOREIGN-BODY REACTION; IMMUNOENZYME TECHNIQUES; POLYURETHANES; RATS; RATS, WISTAR; SILICONE GELS; SURFACE PROPERTIES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 78650045979     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181f446d5     Document Type: Article

References (52)

1. Benlier E, Unal Y, Usta U, Top H, Aygit AC. Effect of verapamil on reduction of peri-implant capsular thickness. Aesthetic Plast Surg. 2009;33:570-575.
2. Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg. 1999;23:197-206.
3. Minami E, Koh IH, Ferreira JC, et al. The composition and behavior of capsules around smooth and textured breast implants in pigs. Plast Reconstr Surg. 2006;118:874-884.
4. Zimman OA, Toblli J, Stella I, Ferder M, Ferder L, Inserra F. The effects of angiotensin-converting enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg. 2007;120:2025-2033.
5. Adams WP. Capsular contracture: What is it? What causes it? How can it be prevented and managed? Clin Plast Surg. 2009; 36:119-126.
6. Bern S, Burd A, May JW Jr. The biophysical and histologic properties of capsules formed by smooth and textured silicone implants in the rabbit. Plast Reconstr Surg. 1992;89:1037-1044.
7. Ibrahim Canter H, Konas E, Bozdogan O, et al. Effect of slow-release 5-fluorouracil on capsule formation around silicone breast implants: An experimental study with mice. Aesthetic Plast Surg. 2007;31:674-679.
8. Poeppl N, Schreml S, Lichteneger F, Lenich A, Eisenmann- Klein M, Prantl L. Does the surface structure of implants have an impact on the formation of a capsular contracture? Aesthetic Plast Surg. 2007;31:133-139.
9. Moreira M, Fagundes DJ, de Jesus SimõesM, de Oliveira MC, Dos Santos Previdelli IT, Moreira AC. Zafirlukast pocket delivery impairs the capsule healing around textured implants in rats. Aesthetic Plast Surg. 2009;33:90-97.
10. Scuderi N, Mazzocchi M, Fioramonti P, Bistoni G. The effects of zafirlukast on capsular contracture: Preliminary report. Aesthetic Plast Surg. 2006;30:513-520.
11. Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: A systematic review. Plast Reconstr Surg. 2006;118:1224-1236.
12. Ersek RA. Molecular impact surface textured implants (MISTI) alter beneficially capsule formation at 36 months. J Long Term Eff Med Implants 1991;1:155-169.
13. Hester TR Jr, Tebbetts JB, Maxwell GP. The polyurethanecovered mammary prosthesis: Facts and fiction (II). A look back and a "peek" ahead. Clin Plast Surg. 2001;28:579-586.
14. Hester TR Jr, Nahai F, Bostwick J, Cukic J. A 5-year experience with polyurethane-covered mammary prostheses for treatment of capsular contracture, primary augmentation mammoplasty, and breast reconstruction. Clin Plast Surg. 1988;15:569-585.
15. Lilla JA, Vistes LM. Long-term study of reactions to various silicone breast implants in rabbits. Plast Reconstr Surg. 1976; 57:637-649.
16. Brand KG. Foam-covered mammary implants. Clin Plast Surg. 1988;15:533-539.
17. Dunn KW, Hall PN, Khoo CT. Breast implant materials: Sense and safety. Br J Plast Surg. 1992;45:315-321.
18. Burkhardt BR, Fried M, Schnur PL, Tofield JJ. Capsules, infection, and intraluminal antibiotics. Plast Reconstr Surg. 1981;68:43-49.
19. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199-210.
20. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349-363.
21. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146.
22. Gancedo M, Ruiz-Corro L, Salazar-Montes A, Rincon AR, Armendariz-Borunda J. Pirfenidone prevents capsular contracture after mammary implantation. Aesthetic Plast Surg. 2008;32:32-40.
23. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
24. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells Mol Dis. 2007;38:258-268.
25. Knetsch ML, Koole LH. VEGF-E enhances endothelialization and inhibits thrombus formation on polymeric surfaces. J Biomed Mater Res A 2010;93:77-85.
26. Greisler HP, Gosselin C, Ren D, Kang SS, Kim DU. Biointeractive polymers and tissue engineered blood vessels. Biomaterials 1996;17:329-336.
27. Howdieshell TR, Callaway D, Webb WL, et al. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res. 2001;96:173-182.
28. Ito Y, Hasuda H, Terai H, Kitajima T. Culture of human umbilical vein endothelial cells on immobilized vascular endothelial growth factor. J Biomed Mater Res A 2005;74:659-665.
29. Koch S, Yao C, Grieb G, Prevel P, Noah EM, Steffens GC. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med. 2006;17: 735-741.
30. Medeiros R, Rodrigues GB, Figueiredo CP, et al. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis. Mol Pharmacol. 2008;74: 154-161.
31. Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB. Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br J Pharmacol. 2009;157:1034-1044.
32. Smahel J. Histology of the capsules causing constrictive fibrosis around breast implants. Plast Reconstr Surg. 1977;30: 324-329.
33. Brohim RM, Foresman PA, Grant GM, Merickel MB, Rodeheaver GT. Quantitative monitoring of capsular contraction around smooth and textured implants. Ann Plast Surg. 1993; 30:424-434.
34. Brohim RM, Foresman PA, Hildebrandt PK, Rodeheaver GT. Early tissue reaction to textured breast implant surfaces. Ann Plast Surg. 1992;28:354-362.
35. Clugston PA, Perry LC, Hammond DC, Maxwell GP. A rat model for capsular contracture: The effects of surface texturing. Ann Plast Surg. 1994;33:595-599.
36. Ksander GA, Vistnes LM, Kosek J. Effect of implant location on compressibility and capsule formation around miniprostheses in rats, and experimental capsule contracture. Ann Plast Surg. 1981;6:182-193.
37. Batra M, Bernard S, Picha G. Histologic comparison of breast implant shells with smooth, foam, and pillar microstructuring in a rat model from 1 day to 6 months. Plast Reconstr Surg. 1995;95:354-363.
38. Picha GJ, Goldstein JA. Analysis of the soft-tissue response to components used in the manufacture of breast implants: Rat animal model. Plast Reconstr Surg. 1991;87:490-500.
39. Picha GJ, Goldstein JA, Stohr E. Natural-Y Même polyurethane versus smooth silicone: Analysis of the soft-tissue interaction from 3 days to 1 year in the rat animal model. Plast Reconstr Surg. 1990;85:903-916.
40. Sank A, Chalabian-Baliozian J, Ertl D, Sherman R, Nimni M, Tuan TL. Cellular responses to silicone and polyurethane prosthetic surfaces. J Surg Res. 1993;54:12-20.
41. Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering materials. Biomaterials 2005;26:7457-7470.
42. Bucky LP, Ehrlich HP, Sohoni S, May JW Jr. The capsule quality of saline-filled smooth silicone, textured silicone, and polyurethane implants in rabbits: A long-term study. Plast Reconstr Surg. 1994;93:1123-1131; discussion 1132-1133.
43. Adams WP, Haydon MS Jr, Raniere J, et al. A rabbit model for capsular contracture: Development and clinical implications. Plast Reconstr Surg. 2006;117:1214-1219; discussion 1220-1221.
44. Bastos EM, Neto MS, Alves MT, et al. Histologic analysis of zafirlukast's effect on capsule formation around silicone implants. Aesthetic Plast Surg. 2007;31:559-565.
45. Rubino C, Mazzarello V, Farace F, et al. Ultrastructural anatomy of contracted capsules around textured implants in augmented breasts. Ann Plast Surg. 2001;46:95-113.
46. Jones KS. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol. 2008;20:130-136.
47. Davies N, Dobner S, Bezuidenhout D, et al. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 2008;29:3531-3538.
48. Schmidt C, Bezuidenhout D, Beck M, Van der Merwe E, Zilla P, Davies N. Rapid three-dimensional quantification of VEGF-induced scaffold neovascularisation by microcomputed tomography. Biomaterials 2009;30:5959-5968.
49. Prantl L, Schreml S, Fichtner-Feigl S, et al. Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg. 2007; 120:275-284.
50. Ruiz-de-Erenchum R, Herrerías D, Hontanilla B. Use of the transforming growth factor-1 inhibitor peptide in periprosthetic capsular fibrosis: Experimental model with tetraglycerol dipalmitate. Plast Reconstr Surg. 2005;116:1370-1378.
51. Carter D. Tissue reaction to breast implants. Am J Clin Pathol. 1994;102:565-566.
52. Khun A, Singh S, Smith PD. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann Plast Surg. 2000;44:387-391.